Treatment of Idiopathic Perifoveal Telangiectasia (IPT) With Open-Label Anecortave Acetate (15mg.).
Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
Idiopathic Perifoveal telangiectasia is a poorly understood disorder that involves the growth
of blood vessels around the center of the macula(perifoveal region). These blood vessels may
extrend beneath the retina to produce an area of sub-retinal neosvascularization(growth of
abnormal blood vessels under the retina which "leak" fluid, causing reduction in vision.
Limited forms of treatment are available in managing the neovascularization and its
consequences. Anecortave Acetate injection is considered as an attempt to control the growth
of the abnormal blood vessels.